THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS

The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SÁNCHEZ-QUESADA, JORGE, OLGA MARTÍNEZ MONTERO, BEATRIZ RODRÍGUEZ SALGUERO, JAVIER LÓPEZ OGALLA, SUSANA HERRERO SANTOS, MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO, MIGUEL MEDINA PADILLA, JAVIER DE CRISTOBAL BLANCO, JUAN MANUEL DOMÍNGUEZ CORREA, ANA FUERTES HUERTA, FRANCISCO PALOMO NICOLAU
Format: Patent
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SÁNCHEZ-QUESADA, JORGE
OLGA MARTÍNEZ MONTERO
BEATRIZ RODRÍGUEZ SALGUERO
JAVIER LÓPEZ OGALLA
SUSANA HERRERO SANTOS
MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO
MIGUEL MEDINA PADILLA
JAVIER DE CRISTOBAL BLANCO
JUAN MANUEL DOMÍNGUEZ CORREA
ANA FUERTES HUERTA
FRANCISCO PALOMO NICOLAU
description The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT2838888TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT2838888TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT2838888TT3</originalsourceid><addsrcrecordid>eNrjZNAM8fB0dPF0jPL38XTx9HN18fT3cw1WcAxWcA_21jVW8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEBIUYWxhZAEBJiTIQSAPd1JKQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><source>esp@cenet</source><creator>SÁNCHEZ-QUESADA, JORGE ; OLGA MARTÍNEZ MONTERO ; BEATRIZ RODRÍGUEZ SALGUERO ; JAVIER LÓPEZ OGALLA ; SUSANA HERRERO SANTOS ; MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO ; MIGUEL MEDINA PADILLA ; JAVIER DE CRISTOBAL BLANCO ; JUAN MANUEL DOMÍNGUEZ CORREA ; ANA FUERTES HUERTA ; FRANCISCO PALOMO NICOLAU</creator><creatorcontrib>SÁNCHEZ-QUESADA, JORGE ; OLGA MARTÍNEZ MONTERO ; BEATRIZ RODRÍGUEZ SALGUERO ; JAVIER LÓPEZ OGALLA ; SUSANA HERRERO SANTOS ; MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO ; MIGUEL MEDINA PADILLA ; JAVIER DE CRISTOBAL BLANCO ; JUAN MANUEL DOMÍNGUEZ CORREA ; ANA FUERTES HUERTA ; FRANCISCO PALOMO NICOLAU</creatorcontrib><description>The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</description><language>eng ; por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170718&amp;DB=EPODOC&amp;CC=PT&amp;NR=2838888T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170718&amp;DB=EPODOC&amp;CC=PT&amp;NR=2838888T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SÁNCHEZ-QUESADA, JORGE</creatorcontrib><creatorcontrib>OLGA MARTÍNEZ MONTERO</creatorcontrib><creatorcontrib>BEATRIZ RODRÍGUEZ SALGUERO</creatorcontrib><creatorcontrib>JAVIER LÓPEZ OGALLA</creatorcontrib><creatorcontrib>SUSANA HERRERO SANTOS</creatorcontrib><creatorcontrib>MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO</creatorcontrib><creatorcontrib>MIGUEL MEDINA PADILLA</creatorcontrib><creatorcontrib>JAVIER DE CRISTOBAL BLANCO</creatorcontrib><creatorcontrib>JUAN MANUEL DOMÍNGUEZ CORREA</creatorcontrib><creatorcontrib>ANA FUERTES HUERTA</creatorcontrib><creatorcontrib>FRANCISCO PALOMO NICOLAU</creatorcontrib><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><description>The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAM8fB0dPF0jPL38XTx9HN18fT3cw1WcAxWcA_21jVW8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEBIUYWxhZAEBJiTIQSAPd1JKQ</recordid><startdate>20170718</startdate><enddate>20170718</enddate><creator>SÁNCHEZ-QUESADA, JORGE</creator><creator>OLGA MARTÍNEZ MONTERO</creator><creator>BEATRIZ RODRÍGUEZ SALGUERO</creator><creator>JAVIER LÓPEZ OGALLA</creator><creator>SUSANA HERRERO SANTOS</creator><creator>MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO</creator><creator>MIGUEL MEDINA PADILLA</creator><creator>JAVIER DE CRISTOBAL BLANCO</creator><creator>JUAN MANUEL DOMÍNGUEZ CORREA</creator><creator>ANA FUERTES HUERTA</creator><creator>FRANCISCO PALOMO NICOLAU</creator><scope>EVB</scope></search><sort><creationdate>20170718</creationdate><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><author>SÁNCHEZ-QUESADA, JORGE ; OLGA MARTÍNEZ MONTERO ; BEATRIZ RODRÍGUEZ SALGUERO ; JAVIER LÓPEZ OGALLA ; SUSANA HERRERO SANTOS ; MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO ; MIGUEL MEDINA PADILLA ; JAVIER DE CRISTOBAL BLANCO ; JUAN MANUEL DOMÍNGUEZ CORREA ; ANA FUERTES HUERTA ; FRANCISCO PALOMO NICOLAU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT2838888TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SÁNCHEZ-QUESADA, JORGE</creatorcontrib><creatorcontrib>OLGA MARTÍNEZ MONTERO</creatorcontrib><creatorcontrib>BEATRIZ RODRÍGUEZ SALGUERO</creatorcontrib><creatorcontrib>JAVIER LÓPEZ OGALLA</creatorcontrib><creatorcontrib>SUSANA HERRERO SANTOS</creatorcontrib><creatorcontrib>MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO</creatorcontrib><creatorcontrib>MIGUEL MEDINA PADILLA</creatorcontrib><creatorcontrib>JAVIER DE CRISTOBAL BLANCO</creatorcontrib><creatorcontrib>JUAN MANUEL DOMÍNGUEZ CORREA</creatorcontrib><creatorcontrib>ANA FUERTES HUERTA</creatorcontrib><creatorcontrib>FRANCISCO PALOMO NICOLAU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SÁNCHEZ-QUESADA, JORGE</au><au>OLGA MARTÍNEZ MONTERO</au><au>BEATRIZ RODRÍGUEZ SALGUERO</au><au>JAVIER LÓPEZ OGALLA</au><au>SUSANA HERRERO SANTOS</au><au>MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO</au><au>MIGUEL MEDINA PADILLA</au><au>JAVIER DE CRISTOBAL BLANCO</au><au>JUAN MANUEL DOMÍNGUEZ CORREA</au><au>ANA FUERTES HUERTA</au><au>FRANCISCO PALOMO NICOLAU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><date>2017-07-18</date><risdate>2017</risdate><abstract>The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; por
recordid cdi_epo_espacenet_PT2838888TT
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A51%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=S%C3%81NCHEZ-QUESADA,%20JORGE&rft.date=2017-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT2838888TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true